Cargando…

Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies

Thermoresponsive drug delivery systems are designed for the controlled and targeted release of therapeutic payload. These systems exploit hyperthermic temperatures (>39°C), which may be applied by some external means or due to an encountered symptom in inflammatory diseases such as cancer and art...

Descripción completa

Detalles Bibliográficos
Autores principales: Rehman, Mubashar, Ihsan, Ayesha, Madni, Asadullah, Bajwa, Sadia Zafar, Shi, Di, Webster, Thomas J, Khan, Waheed S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701611/
https://www.ncbi.nlm.nih.gov/pubmed/29200845
http://dx.doi.org/10.2147/IJN.S147506
_version_ 1783281378412986368
author Rehman, Mubashar
Ihsan, Ayesha
Madni, Asadullah
Bajwa, Sadia Zafar
Shi, Di
Webster, Thomas J
Khan, Waheed S
author_facet Rehman, Mubashar
Ihsan, Ayesha
Madni, Asadullah
Bajwa, Sadia Zafar
Shi, Di
Webster, Thomas J
Khan, Waheed S
author_sort Rehman, Mubashar
collection PubMed
description Thermoresponsive drug delivery systems are designed for the controlled and targeted release of therapeutic payload. These systems exploit hyperthermic temperatures (>39°C), which may be applied by some external means or due to an encountered symptom in inflammatory diseases such as cancer and arthritis. The objective of this paper was to provide some solid evidence in support of the hypothesis that solid lipid nanoparticles (SLNs) can be used for thermoresponsive targeting by undergoing solid–liquid phase transition at their melting point (MP). Thermoresponsive lipid mixtures were prepared by mixing solid and liquid natural fatty acids, and their MP was measured by differential scanning calorimetry (DSC). SLNs (MP 39°C) containing 5-fluorouracil (5-FU) were synthesized by hot melt encapsulation method, and were found to have spherical shape (transmission electron microscopy studies), desirable size (<200 nm), and enhanced physicochemical stability (Fourier transform infrared spectroscopy analysis). We observed a sustained release pattern (22%–34%) at 37°C (5 hours). On the other hand, >90% drug was released at 39°C after 5 hours, suggesting that the SLNs show thermoresponsive drug release, thus confirming our hypothesis. Drug release from SLNs at 39°C was similar to oleic acid and linoleic acid nanoemulsions used in this study, which further confirmed that thermoresponsive drug release is due to solid–liquid phase transition. Next, a differential pulse voltammetry-based electrochemical chemical detection method was developed for quick and real-time analysis of 5-FU release, which also confirmed thermoresponsive drug release behavior of SLNs. Blank SLNs were found to be biocompatible with human gingival fibroblast cells, although 5-FU-loaded SLNs showed some cytotoxicity after 24 hours. 5-FU-loaded SLNs showed thermoresponsive cytotoxicity to breast cancer cells (MDA-MB-231) as cytotoxicity was higher at 39°C (cell viability 72%–78%) compared to 37°C (cell viability >90%) within 1 hour. In conclusion, this study presents SLNs as a safe, simple, and effective platform for thermoresponsive targeting.
format Online
Article
Text
id pubmed-5701611
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57016112017-11-30 Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies Rehman, Mubashar Ihsan, Ayesha Madni, Asadullah Bajwa, Sadia Zafar Shi, Di Webster, Thomas J Khan, Waheed S Int J Nanomedicine Original Research Thermoresponsive drug delivery systems are designed for the controlled and targeted release of therapeutic payload. These systems exploit hyperthermic temperatures (>39°C), which may be applied by some external means or due to an encountered symptom in inflammatory diseases such as cancer and arthritis. The objective of this paper was to provide some solid evidence in support of the hypothesis that solid lipid nanoparticles (SLNs) can be used for thermoresponsive targeting by undergoing solid–liquid phase transition at their melting point (MP). Thermoresponsive lipid mixtures were prepared by mixing solid and liquid natural fatty acids, and their MP was measured by differential scanning calorimetry (DSC). SLNs (MP 39°C) containing 5-fluorouracil (5-FU) were synthesized by hot melt encapsulation method, and were found to have spherical shape (transmission electron microscopy studies), desirable size (<200 nm), and enhanced physicochemical stability (Fourier transform infrared spectroscopy analysis). We observed a sustained release pattern (22%–34%) at 37°C (5 hours). On the other hand, >90% drug was released at 39°C after 5 hours, suggesting that the SLNs show thermoresponsive drug release, thus confirming our hypothesis. Drug release from SLNs at 39°C was similar to oleic acid and linoleic acid nanoemulsions used in this study, which further confirmed that thermoresponsive drug release is due to solid–liquid phase transition. Next, a differential pulse voltammetry-based electrochemical chemical detection method was developed for quick and real-time analysis of 5-FU release, which also confirmed thermoresponsive drug release behavior of SLNs. Blank SLNs were found to be biocompatible with human gingival fibroblast cells, although 5-FU-loaded SLNs showed some cytotoxicity after 24 hours. 5-FU-loaded SLNs showed thermoresponsive cytotoxicity to breast cancer cells (MDA-MB-231) as cytotoxicity was higher at 39°C (cell viability 72%–78%) compared to 37°C (cell viability >90%) within 1 hour. In conclusion, this study presents SLNs as a safe, simple, and effective platform for thermoresponsive targeting. Dove Medical Press 2017-11-21 /pmc/articles/PMC5701611/ /pubmed/29200845 http://dx.doi.org/10.2147/IJN.S147506 Text en © 2017 Rehman et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Rehman, Mubashar
Ihsan, Ayesha
Madni, Asadullah
Bajwa, Sadia Zafar
Shi, Di
Webster, Thomas J
Khan, Waheed S
Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies
title Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies
title_full Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies
title_fullStr Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies
title_full_unstemmed Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies
title_short Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies
title_sort solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701611/
https://www.ncbi.nlm.nih.gov/pubmed/29200845
http://dx.doi.org/10.2147/IJN.S147506
work_keys_str_mv AT rehmanmubashar solidlipidnanoparticlesforthermoresponsivetargetingevidencefromspectrophotometryelectrochemicalandcytotoxicitystudies
AT ihsanayesha solidlipidnanoparticlesforthermoresponsivetargetingevidencefromspectrophotometryelectrochemicalandcytotoxicitystudies
AT madniasadullah solidlipidnanoparticlesforthermoresponsivetargetingevidencefromspectrophotometryelectrochemicalandcytotoxicitystudies
AT bajwasadiazafar solidlipidnanoparticlesforthermoresponsivetargetingevidencefromspectrophotometryelectrochemicalandcytotoxicitystudies
AT shidi solidlipidnanoparticlesforthermoresponsivetargetingevidencefromspectrophotometryelectrochemicalandcytotoxicitystudies
AT websterthomasj solidlipidnanoparticlesforthermoresponsivetargetingevidencefromspectrophotometryelectrochemicalandcytotoxicitystudies
AT khanwaheeds solidlipidnanoparticlesforthermoresponsivetargetingevidencefromspectrophotometryelectrochemicalandcytotoxicitystudies